Need a Lung but You’ve Got DSA - What Can Be Done?
Thursday, July 17, 2014 - 2pm Montreal time (1pm Winnipeg)		TTS-CST Webinar

Speaker:		Kathryn Tinckam, MD MMSc FRCPC Department of Medicine, Division of Nephrology Co-director HLA Laboratory University Health Network, University of Toronto
Moderator:		Peter Nickerson, MD, FRCPC Medical Consultant, Transplant Immunology Laboratory, DSM Associate Dean (Research), Internal Medicine Flynn Family Chair in Renal Transplantation Professor, Internal Medicine and Immunology University of Manitoba

Overview:

Pre-transplant sensitization to HLA antibodies in lung transplantation is associated with increased rejection and worse allograft survival. We will review the extent impact of HLA antibodies in lung transplantation, as well as options available to sensitized lung transplant candidates including avoidance of HLA antibodies, and desensitization strategies, with an emphasis on short and long term transplant outcomes.

Biography:

Dr. Kathryn Tinckam is a transplant nephrologist and co-director of the HLA laboratory at the University Health Network in Toronto, Canada. She received her Internal Medicine Training at the University of Manitoba, Nephrology and Transplant Fellowships at the University of British Columbia, and completed her Histocompatibility and Immunogenetics Training at Harvard University. Her clinical interest is in acute and chronic antibody mediated complications in all solid organ transplants and her research focus is on the application of HLA antibody diagnostics pre and post transplant.